SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-074460
Filing Date
2020-06-18
Accepted
2020-06-18 09:40:22
Documents
13
Period of Report
2020-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022873d1_8k.htm   iXBRL 8-K 30914
2 EXHIBIT 10.1 tm2022873d1_ex10-1.htm EX-10.1 344911
  Complete submission text file 0001104659-20-074460.txt   614724

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA akrx-20200617.xsd EX-101.SCH 3177
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE akrx-20200617_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akrx-20200617_pre.xml EX-101.PRE 22706
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2022873d1_8k_htm.xml XML 3610
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 20971386
SIC: 2834 Pharmaceutical Preparations